REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 189 filers reported holding REATA PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 0.71 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $2,246,000 | +54.4% | 68,569 | +24.3% | 0.02% | +69.2% |
Q4 2021 | $1,455,000 | -70.5% | 55,172 | +12.7% | 0.01% | -71.7% |
Q3 2021 | $4,924,000 | -30.1% | 48,935 | -1.7% | 0.05% | -29.2% |
Q2 2021 | $7,042,000 | +63.0% | 49,757 | +14.9% | 0.06% | +51.2% |
Q1 2021 | $4,319,000 | -14.9% | 43,320 | +5.5% | 0.04% | -15.7% |
Q4 2020 | $5,075,000 | +35.8% | 41,056 | +7.0% | 0.05% | +21.4% |
Q3 2020 | $3,738,000 | -37.4% | 38,370 | +0.2% | 0.04% | -40.8% |
Q2 2020 | $5,975,000 | +53.0% | 38,298 | +41.5% | 0.07% | +29.1% |
Q1 2020 | $3,906,000 | -12.7% | 27,059 | +23.6% | 0.06% | +12.2% |
Q4 2019 | $4,476,000 | +420.5% | 21,894 | +104.3% | 0.05% | +390.0% |
Q3 2019 | $860,000 | -14.9% | 10,716 | 0.0% | 0.01% | -16.7% |
Q2 2019 | $1,011,000 | – | 10,716 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CPMG Inc | 2,896,901 | $295,368,026 | 59.26% |
Ally Bridge Group (NY) LLC | 105,558 | $10,762,694 | 13.04% |
First Light Asset Management, LLC | 1,432,208 | $146,027,928 | 11.44% |
Boxer Capital, LLC | 1,430,004 | $145,803 | 6.76% |
MPM BioImpact LLC | 234,478 | $23,907,377 | 4.81% |
Tri Locum Partners LP | 96,274 | $9,816,097 | 3.65% |
Altium Capital Management LP | 41,485 | $4,229,811 | 3.20% |
Ghost Tree Capital, LLC | 85,000 | $8,666,600 | 2.86% |
KRS Capital Management, LLC | 27,941 | $2,848,864 | 2.85% |
Sofinnova Investments, Inc. | 322,471 | $32,879,143 | 2.15% |